HER2 Support Group Forums - View Single Post - Risk of Recurrent Disease in HER2-Positive Patients

Hopeful · 03-11-2010, 12:34 PM

I think an important part of the discussion is the recognition that ER+ Her2+ patients need continual dual blockade, i.e., the system of one year of Herceptin and 5 years of endocrine therapy is not optimal. I was very uncomfortable continuing endocrine therapy w/o some corresponding anti-Her2 therapy.

Hopeful

03-11-2010, 12:34 PM	#4
Hopeful Senior Member Join Date: Aug 2006 Posts: 3,380	Re: Risk of Recurrent Disease in HER2-Positive Patients I think an important part of the discussion is the recognition that ER+ Her2+ patients need continual dual blockade, i.e., the system of one year of Herceptin and 5 years of endocrine therapy is not optimal. I was very uncomfortable continuing endocrine therapy w/o some corresponding anti-Her2 therapy. Hopeful